A cluster-randomised, non-inferiority trial of the impact of a two-dose compared to three-dose schedule of pneumococcal conjugate vaccination in rural Gambia: the PVS trial
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1745-6215
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
A cluster-randomised, non-inferiority trial of the impact of a two-dose compared to three-dose schedule of pneumococcal conjugate vaccination in rural Gambia: the PVS trial ; volume:23 ; number:1 ; day:24 ; month:1 ; year:2022 ; pages:1-23 ; date:12.2022
Trials ; 23, Heft 1 (24.1.2022), 1-23, 12.2022
- Urheber
-
Mackenzie, Grant A.
Osei, Isaac
Salaudeen, Rasheed
Hossain, Ilias
Young, Benjamin
Secka, Ousman
D’Alessandro, Umberto
Palmu, Arto A.
Jokinen, Jukka
Hinds, Jason
Flasche, Stefan
Mulholland, Kim
Nguyen, Cattram
Greenwood, Brian
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13063-021-05964-5
- URN
-
urn:nbn:de:101:1-2022050419541576280383
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:23 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mackenzie, Grant A.
- Osei, Isaac
- Salaudeen, Rasheed
- Hossain, Ilias
- Young, Benjamin
- Secka, Ousman
- D’Alessandro, Umberto
- Palmu, Arto A.
- Jokinen, Jukka
- Hinds, Jason
- Flasche, Stefan
- Mulholland, Kim
- Nguyen, Cattram
- Greenwood, Brian
- SpringerLink (Online service)
Ähnliche Objekte (12)
Dose response of ACE inhibitors: implications of the SECURE trial
Comparison of two doses of leucovorin in severe low-dose methotrexate toxicity – a randomized controlled trial
Importance of dose-schedule of 5-aza-2'-deoxycytidine for epigenetic therapy of cancer
Adaptive design for identifying maximum tolerated dose early to accelerate dose-finding trial
Once weekly paclitaxel associated with a fixed dose of oral metronomic cyclophosphamide: a dose-finding phase 1 trial
The one-dose schedule opens the door to rapid scale-up of HPV vaccination
Determination of the median effective dose (ED50) of bupivacaine and ropivacaine unilateral spinal anesthesia : Prospective, double blinded, randomized dose-response trial
Pneumococcal vaccine schedules (PVS) study: a cluster-randomised, non-inferiority trial of an alternative versus standard schedule for pneumococcal conjugate vaccination—statistical analysis plan
Effects of the dose of erythropoiesis stimulating agents on cardiovascular events, quality of life, and health-related costs in hemodialysis patients: the clinical evaluation of the dose of erythropoietins (C.E. DOSE) trial protocol
OA09.01. Massage therapy for osteoarthritis of the knee: a randomized dose-finding trial
Pilot trial of high-dose vitamin C in critically ill COVID-19 patients
Relugolix for oral treatment of uterine leiomyomas: a dose-finding, randomized, controlled trial
Dose response of ACE inhibitors: implications of the SECURE trial
Comparison of two doses of leucovorin in severe low-dose methotrexate toxicity – a randomized controlled trial
Importance of dose-schedule of 5-aza-2'-deoxycytidine for epigenetic therapy of cancer
Adaptive design for identifying maximum tolerated dose early to accelerate dose-finding trial
Once weekly paclitaxel associated with a fixed dose of oral metronomic cyclophosphamide: a dose-finding phase 1 trial
The one-dose schedule opens the door to rapid scale-up of HPV vaccination
Determination of the median effective dose (ED50) of bupivacaine and ropivacaine unilateral spinal anesthesia : Prospective, double blinded, randomized dose-response trial
Pneumococcal vaccine schedules (PVS) study: a cluster-randomised, non-inferiority trial of an alternative versus standard schedule for pneumococcal conjugate vaccination—statistical analysis plan
Effects of the dose of erythropoiesis stimulating agents on cardiovascular events, quality of life, and health-related costs in hemodialysis patients: the clinical evaluation of the dose of erythropoietins (C.E. DOSE) trial protocol
OA09.01. Massage therapy for osteoarthritis of the knee: a randomized dose-finding trial
Pilot trial of high-dose vitamin C in critically ill COVID-19 patients
Relugolix for oral treatment of uterine leiomyomas: a dose-finding, randomized, controlled trial
Dose response of ACE inhibitors: implications of the SECURE trial
Comparison of two doses of leucovorin in severe low-dose methotrexate toxicity – a randomized controlled trial
Importance of dose-schedule of 5-aza-2'-deoxycytidine for epigenetic therapy of cancer
Adaptive design for identifying maximum tolerated dose early to accelerate dose-finding trial
Once weekly paclitaxel associated with a fixed dose of oral metronomic cyclophosphamide: a dose-finding phase 1 trial
The one-dose schedule opens the door to rapid scale-up of HPV vaccination
Determination of the median effective dose (ED50) of bupivacaine and ropivacaine unilateral spinal anesthesia : Prospective, double blinded, randomized dose-response trial
Pneumococcal vaccine schedules (PVS) study: a cluster-randomised, non-inferiority trial of an alternative versus standard schedule for pneumococcal conjugate vaccination—statistical analysis plan
Effects of the dose of erythropoiesis stimulating agents on cardiovascular events, quality of life, and health-related costs in hemodialysis patients: the clinical evaluation of the dose of erythropoietins (C.E. DOSE) trial protocol
OA09.01. Massage therapy for osteoarthritis of the knee: a randomized dose-finding trial
Pilot trial of high-dose vitamin C in critically ill COVID-19 patients